Multiple Sclerosis Research Review Issue 85
In this issue:
GEMINI 1 & 2: tolebrutinib vs. teriflunomide in relapsing MS
HERCULES: tolebrutinib in non-relapsing SPMS
Three distinct endophenotypes of MS
Broad rim lesions as a biomarker for rapid disease progression in MS
PIRA as an outcome measure in RRMS clinical trials
Coffee intake & MS risk
LymphoTEC: real-world lymphocyte reconstitution after lymphopaenia with dimethyl fumarate in RRMS
MS diagnosis based on extensive DIS alone
Repeated COVID-19 vaccination in patients with MS receiving ocrelizumab
Complement activation profiles reflect structural brain damage in MS
Expert contributor
Clinical Professor Todd Hardy
Clinical Professor Todd Hardy is Staff Specialist Neurologist at Concord Hospital, Clinical Senior Lecturer in Medicine at the University of Sydney and Co-Director of the MS Clinic at the Brain & Mind Centre. Dr Hardy’s clinical and research interests are in the field of neuroimmunology. His main focus is on multiple sclerosis, including atypical forms […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.